Literature DB >> 21272227

Use of metabolomic profiling in the study of arachidonic acid metabolism in cardiovascular disease.

Ning Li1, Jun-Yan Liu, Hong Qiu, Todd R Harris, Padmini Sirish, Bruce D Hammock, Nipavan Chiamvimonvat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21272227      PMCID： PMC3583533          DOI： 10.1111/j.1751-7133.2010.00209.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN： 1527-5299


× No keyword cloud information.
  52 in total

1.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Wayne Rosamond; Katherine Flegal; Gary Friday; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher J O'Donnell; Veronique Roger; John Rumsfeld; Paul Sorlie; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Yuling Hong
Journal:  Circulation       Date:  2006-12-28       Impact factor: 29.690

2.  Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors.

Authors:  Kara R Schmelzer; Bora Inceoglu; Lukas Kubala; In-Hae Kim; Steven L Jinks; Jason P Eiserich; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-01       Impact factor: 11.205

3.  Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors.

Authors:  Danyan Xu; Ning Li; Yuxia He; Valeriy Timofeyev; Ling Lu; Hsing-Ju Tsai; In-Hae Kim; Dipika Tuteja; Robertino Karlo P Mateo; Anil Singapuri; Benjamin B Davis; Reginald Low; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-27       Impact factor: 11.205

Review 4.  The soluble epoxide hydrolase as a pharmaceutical target for hypertension.

Authors:  Nipavan Chiamvimonvat; Chin-Min Ho; Hsing-Ju Tsai; Bruce D Hammock
Journal:  J Cardiovasc Pharmacol       Date:  2007-09       Impact factor: 3.105

Review 5.  Immune modulation: role of the inflammatory cytokine cascade in the failing human heart.

Authors:  Mamoru Satoh; Yoshitaka Minami; Yuji Takahashi; Motoyuki Nakamura
Journal:  Curr Heart Fail Rep       Date:  2008-06

6.  Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.

Authors:  Jan Monti; Judith Fischer; Svetlana Paskas; Matthias Heinig; Herbert Schulz; Claudia Gösele; Arnd Heuser; Robert Fischer; Cosima Schmidt; Alexander Schirdewan; Volkmar Gross; Oliver Hummel; Henrike Maatz; Giannino Patone; Kathrin Saar; Martin Vingron; Steven M Weldon; Klaus Lindpaintner; Bruce D Hammock; Klaus Rohde; Rainer Dietz; Stuart A Cook; Wolf-Hagen Schunck; Friedrich C Luft; Norbert Hubner
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

7.  Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.

Authors:  Garrett J Gross; Kathryn M Gauthier; Jeannine Moore; John R Falck; Bruce D Hammock; William B Campbell; Kasem Nithipatikom
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-25       Impact factor: 4.733

8.  Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques.

Authors:  William R Wikoff; Gurudutt Pendyala; Gary Siuzdak; Howard S Fox
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

9.  Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation.

Authors:  Michael P Hutchens; Takaaki Nakano; Jennifer Dunlap; Richard J Traystman; Patricia D Hurn; Nabil J Alkayed
Journal:  Resuscitation       Date:  2007-08-28       Impact factor: 5.262

10.  Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension.

Authors:  Jing Li; Mairead A Carroll; Praveen N Chander; John R Falck; Bhavani Sangras; Charles T Stier
Journal:  Front Biosci       Date:  2008-05-01
View more
  23 in total

1.  Distinct differences in serum eicosanoids in healthy, enteritis and colorectal cancer individuals.

Authors:  Junjie Zhang; Qingjin Yang; Jian Li; Yu Zhong; Lijian Zhang; Qionglin Huang; Bin Chen; Mingming Mo; Sensen Shen; Qisheng Zhong; Huwei Liu; Chun Cai
Journal:  Metabolomics       Date:  2017-11-27       Impact factor: 4.290

2.  System-level multi-target drug discovery from natural products with applications to cardiovascular diseases.

Authors:  Chunli Zheng; Jinan Wang; Jianling Liu; Mengjie Pei; Chao Huang; Yonghua Wang
Journal:  Mol Divers       Date:  2014-05-04       Impact factor: 2.943

3.  Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation.

Authors:  Padmini Sirish; Ning Li; Valeriy Timofeyev; Xiao-Dong Zhang; Lianguo Wang; Jun Yang; Kin Sing Stephen Lee; Ahmed Bettaieb; Sin Mei Ma; Jeong Han Lee; Demetria Su; Victor C Lau; Richard E Myers; Deborah K Lieu; Javier E López; J Nilas Young; Ebenezer N Yamoah; Fawaz Haj; Crystal M Ripplinger; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

4.  Cardiac-generated prostanoids mediate cardiac myocyte apoptosis after myocardial ischaemia.

Authors:  Hong Qiu; Jun-Yan Liu; Dongguang Wei; Ning Li; Ebenezer N Yamoah; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Res       Date:  2012-06-15       Impact factor: 10.787

5.  Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome.

Authors:  Michael A Kiebish; Kui Yang; Xinping Liu; David J Mancuso; Shaoping Guan; Zhongdan Zhao; Harold F Sims; Rebekah Cerqua; W Todd Cade; Xianlin Han; Richard W Gross
Journal:  J Lipid Res       Date:  2013-02-14       Impact factor: 5.922

6.  2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion.

Authors:  Peter Bui; Parrisa Solaimani; Xiaomeng Wu; Oliver Hankinson
Journal:  Toxicol Appl Pharmacol       Date:  2011-12-20       Impact factor: 4.219

Review 7.  An eicosanoid-centric view of atherothrombotic risk factors.

Authors:  Scott Gleim; Jeremiah Stitham; Wai Ho Tang; Kathleen A Martin; John Hwa
Journal:  Cell Mol Life Sci       Date:  2012-04-11       Impact factor: 9.261

8.  Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis.

Authors:  Padmini Sirish; Ning Li; Jun-Yan Liu; Kin Sing Stephen Lee; Sung Hee Hwang; Hong Qiu; Cuifen Zhao; Siu Mei Ma; Javier E López; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

9.  3,3',4,4',5-Pentachlorobiphenyl (PCB 126) Decreases Hepatic and Systemic Ratios of Epoxide to Diol Metabolites of Unsaturated Fatty Acids in Male Rats.

Authors:  Xianai Wu; Jun Yang; Christophe Morisseau; Larry W Robertson; Bruce Hammock; Hans-Joachim Lehmler
Journal:  Toxicol Sci       Date:  2016-05-13       Impact factor: 4.849

10.  Myocardial regulation of lipidomic flux by cardiolipin synthase: setting the beat for bioenergetic efficiency.

Authors:  Michael A Kiebish; Kui Yang; Harold F Sims; Christopher M Jenkins; Xinping Liu; David J Mancuso; Zhongdan Zhao; Shaoping Guan; Dana R Abendschein; Xianlin Han; Richard W Gross
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.